AOD 9604 5 mg

Dragon Pharma AOD 9604

AOD 9604 5 mg contains a specialized research peptide comprising the 176-191 amino acid fragment of human growth hormone (hGH). This fragment was isolated after researchers discovered it retained the potent lipolytic (fat-burning) properties of full-length growth hormone but without the undesired effects on blood sugar and bone growth. AOD 9604 works by mimicking the way natural growth hormone signals fat cells to break down stored triglycerides into free fatty acids for energy, a process that becomes less efficient with age and insulin resistance.

For bodybuilders and fitness enthusiasts in the USA, Dragon Pharma AOD 9604 5 mg presents a research subject of particular interest during cutting phases and for targeting stubborn fat areas. Its mechanism is believed to enhance the body's natural ability to mobilize and oxidize fat, especially visceral and abdominal fat, without significantly affecting insulin sensitivity—a key distinction from full-length GH. This makes it a compelling compound for studies on body recomposition. Manufactured by Dragon Pharma in sterile, certified European laboratories, each 5 mg vial of lyophilized powder meets exacting standards of purity and consistency, providing researchers with a reliable tool for metabolic and fat loss studies.

Key Benefits:

• Targeted Fat Mobilization: Mimics the fat-burning fragment of growth hormone to stimulate lipolysis in adipose tissue.
• Minimal Impact on Glucose: Research suggests it promotes fat loss without the pronounced hyperglycemic effects of full GH.
• Stubborn Fat Reduction: Particularly studied for its potential effects on abdominal and visceral fat deposits resistant to diet.
• Muscle-Sparing Properties: The focus on fat metabolism may help preserve lean muscle mass during caloric restriction.
• Optimized Research Concentration: 5 mg per vial is ideal for daily or twice-daily research protocols studying fat metabolism.

Each 2 mL vial contains 5 mg of precisely sequenced AOD 9604 peptide as a lyophilized powder, synthesized and purified under strict quality control protocols in Dragon Pharma's advanced research facilities.

Product Specifications

Usage Guidelines

Research Application Only: This information is derived from scientific literature for educational insight. Dragon Pharma AOD 9604 5 mg is a research chemical for laboratory investigation, not for human use.

In experimental models, AOD 9604 is reconstituted with bacteriostatic water. Its very short half-life means research protocols often involve daily, and sometimes twice-daily, administration to maintain stable plasma levels and study sustained metabolic effects. It is frequently researched in conjunction with diet and exercise models to assess synergistic fat loss. Due to its peptide nature, subcutaneous administration is common in preclinical studies.

• Standard Research Cycle (8-12 weeks): Used in longer-term studies to observe cumulative effects on body composition and specific fat depots, often with daily dosing.
• Stubborn Fat Focus Protocol: Some research targets specific areas (e.g., abdominal) with consistent dosing alongside caloric deficit models for 10+ weeks.

Post Cycle Therapy (PCT):

AOD 9604 does not suppress natural testosterone production, so traditional PCT with Clomid or Toremfine is not indicated. However, research into maintaining metabolic rate and insulin sensitivity post-cycle is relevant. Compounds like Sermorelin (a GHRH) could be studied for natural GH pulse support, or Melatonin for its potential effects on metabolism and appetite regulation in a post-research context.

Supportive Research Compounds:

For comprehensive body composition studies, AOD 9604 is often paired with other metabolic agents. T3 (Cytomel) may be studied for its synergistic effect on metabolic rate, though with caution. For enhancing nutrient partitioning and anabolic environment, Primobolan (Methenolone) is a mild, well-tolerated anabolic that could be part of a larger research design on lean mass preservation during fat loss.

Storage Instructions

Maintaining peptide integrity requires strict adherence to storage protocols.

• Unreconstituted Powder: For long-term stability, store the sealed vial in a freezer at -20°C (-4°F) or below. In this frozen, dry state, AOD 9604 is stable for up to 24 months. Avoid exposure to light and humidity.
• After Reconstitution: Once reconstituted with bacteriostatic water, the solution must be stored in a refrigerator at 2°C to 8°C (36°F to 46°F). The refrigerated solution is typically viable for research use for up to 14-21 days. Do not freeze the liquid solution.
• Best Practices: Label vials with reconstitution date. Use sterile techniques to prevent bacterial growth. Transport reconstituted vials in a cool container if needed.